We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Marketing authorisations granted in 2024
Marketing Authorisation Holders should review their manufacturing processes to identify and, if found, to mitigate the risk of nitrosamine impurities being present.
The Ministry of Defence (MOD) is committed to making it easier for new, innovative, and smaller businesses to enter the defence supply chain.
Use the rolling review route when you want to submit your eCTD dossier in separate parts for pre-assessment instead of making a full consolidated document submission.
Details of the process changes for established medicines, effective from 1 March 2024, which apply specifically to chemical products.
This guidance covers ‘grandfathering’ and managing the lifecycle changes of medicinal products.
Guidance on the decentralised and mutual recognition reliance procedure (MRDCRP) for marketing authorisation applications including information on how to apply.
This guide is to help you and your business understand how to ensure that content on your service is appropriate for children.
An overview of the process including submitting or fast-tracking an application, naming your medicine and paying fees.
Placing a veterinary medicine on the market, including non-medicinal products, medicinal words and phrases, how to obtain advice, report non-compliance.
Decisions made by the MHRA following investigations into complaints about advertising for licensed medicines.
Use this form to transfer a product licence, also known as a marketing authorisation, to a different owner.
This toolkit is for Innovation Passport holders following the Innovative Licensing and Access Pathway (ILAP) and provides activities to support the design and development of medicines.
Culture Secretary Lucy Frazer's speech on the strength of the UK's advertising industry at the Ad Association's LEAD conference.
Use this form to notify the IPO of marketing authorisation for a medicinal or plant protection product, granted after your application for an SPC for that product.
Marketing authorisations (MAs) granted since January 2014.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).